News

Plugging gaps in China’s hepatitis B prevention would be cost effective

BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4420 (Published 28 October 2009) Cite this as: BMJ 2009;339:b4420
  1. Jane Parry
  1. 1Hong Kong

    A country-wide catch-up hepatitis B vaccination programme in China would save thousands of lives and be cost effective, research from Stanford University has shown (Hepatology 2009 Sep 9, doi:10.1002/hep.23310).

    Vaccinating the estimated 150 million children aged 1-19 years who are currently unprotected will cost an estimated $423m (£260m; €281m) but will save the economy $840m, by preventing eight million infections and 65 000 deaths, the researchers found.

    Routine free vaccination of babies against the disease began only in 2002, and serological survey data show that 40% of children …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe